Shitara K, Yamanaka T, Denda T, Tsuji Y, et al. REVERCE: a randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for previously treated metastatic colorectal cancer patients. Ann Oncol 2019;30:259-265.
PMID: 31987423